The European Medicines Agency reported Wednesday that it was the focus of a cyberattack involving some of the data around the first COVID-19 vaccine that’s being distributed in Europe.
In a brief statement yesterday, the EMA – which assesses medicines and vaccines for the European Union – only said it was the subject of a cyberattack and had swiftly launched a full investigation.
A more extensive announcement from U.S. drug company Pfizer and its German partner BioNTech, said the cyberattack centered around some documents relating to the regulatory submission to the EMA for a COVID-19 vaccine candidate from the two companies. The corporate release said the information was stored on an EMA server and had been unlawfully accessed.
Please register to continue.
Already registered? Log in.
Once you register, you'll receive:
The context and insight you need to stay abreast of the most important developments in cybersecurity. CISO and practitioner perspectives; strategy and tactics; solutions and innovation; policy and regulation.
Unlimited access to nearly 20 years of SC Media industry analysis and news-you-can-use.
SC Media’s essential morning briefing for cybersecurity professionals.
One-click access to our extensive program of virtual events, with convenient calendar reminders and ability to earn CISSP credits.